出版醫學有限公司
US ˙ NasdaqGS ˙ US28106W1036

SecurityEDIT / Editas Medicine, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership142,742 shares
Latest Disclosed Value $ 314,032
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series ownership in EDIT / Editas Medicine, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 142,742 shares of Editas Medicine, Inc. (US:EDIT) valued at $314,032 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 142,742 shares of Editas Medicine, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $426,799 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Editas Medicine EC US28106W1036 142,742 0 0.00 314 90.30 0.0071
2025-05-28 2025-03-31 NP Editas Medicine EC US28106W1036 142,742 0 0.00 166 -8.84 0.0040
2025-02-25 2024-12-31 NP Editas Medicine EC US28106W1036 142,742 -22,504 -13.62 181 -67.85 0.0040
2024-11-26 2024-09-30 NP Editas Medicine EC US28106W1036 165,246 11,912 7.77 563 -21.37 0.0107
2024-08-26 2024-06-30 NP Editas Medicine EC US28106W1036 153,334 9,284 6.44 716 -32.96 0.0146
2024-05-28 2024-03-31 NP Editas Medicine EC US28106W1036 144,050 -6,059 -4.04 1,069 -29.74 0.0223
2024-02-26 2023-12-31 NP Editas Medicine EC US28106W1036 150,109 10,617 7.61 1,521 39.71 0.0325
2023-11-28 2023-09-30 NP Editas Medicine EC US28106W1036 139,492 20,303 17.03 1,088 11.02 0.0284
2023-08-25 2023-06-30 NP Editas Medicine EC US28106W1036 119,189 6,657 5.92 981 20.25 0.0233
2023-05-26 2023-03-31 NP Editas Medicine EC US28106W1036 112,532 4,410 4.08 816 -15.02 0.0217
2023-02-24 2022-12-31 NP Editas Medicine EC US28106W1036 108,122 -536 -0.49 959 -27.84 0.0264
2022-11-25 2022-09-30 NP Editas Medicine EC US28106W1036 108,658 2,505 2.36 1,330 5.90 0.0381
2022-08-25 2022-06-30 NP Editas Medicine EC US28106W1036 106,153 0 0.00 1,256 -37.84 0.0347
2022-05-26 2022-03-31 NP Editas Medicine EC US28106W1036 106,153 630 0.60 2,019 -27.92 0.0470
2022-02-25 2021-12-31 NP Editas Medicine EC US28106W1036 105,523 0 0.00 2,802 -35.37 0.0608
2021-11-24 2021-09-30 NP Editas Medicine EC US28106W1036 105,523 0 0.00 4,335 -27.48 0.0955
2021-08-26 2021-06-30 NP Editas Medicine EC US28106W1036 105,523 4,269 4.22 5,977 40.55 0.1282
2021-05-27 2021-03-31 NP Editas Medicine EC US28106W1036 101,254 3,995 4.11 4,253 -37.64 0.0964
2021-02-25 2020-12-31 NP Editas Medicine EC US28106W1036 97,259 -5,199 -5.07 6,819 137.23 0.1747
2020-11-25 2020-09-30 NP Editas Medicine EC US28106W1036 102,458 8,425 8.96 2,875 3.34 0.0923
2020-08-27 2020-06-30 NP Editas Medicine EC US28106W1036 94,033 9,587 11.35 2,781 66.13 0.0909
2020-06-01 2020-03-31 NP Editas Medicine EC US28106W1036 84,446 0 0.00 1,675 -33.04 0.0685
2020-02-27 2019-12-31 NP Editas Medicine EC 28106W103 84,446 8,777 11.60 2,500 45.35 0.0752
2019-11-27 2019-09-30 NP Editas Medicine EC US28106W1036 75,669 75,669 1,721 0.0569
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.